Global Osteoarthritis Pain Drugs Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Osteoarthritis Pain Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Osteoarthritis Pain Drugs Market Size Growth Rate by Type
  • 1.4.2 Oral
  • 1.4.3 Injection
  • 1.2.4 External
• 1.3 Market by Application
  • 1.3.1 Global Osteoarthritis Pain Drugs Market Size Growth Rate by Application
  • 1.3.2 Medical Care
  • 1.3.3 Personal Care
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Osteoarthritis Pain Drugs Sales Estimates and Forecasts 2016-2027
• 2.2 Global Osteoarthritis Pain Drugs Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Osteoarthritis Pain Drugs Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Osteoarthritis Pain Drugs Regions by Sales
  • 2.4.1 Global Top Osteoarthritis Pain Drugs Regions by Sales (2016-2021)
  • 2.4.2 Global Top Osteoarthritis Pain Drugs Regions by Sales (2022-2027)
• 2.5 Global Top Osteoarthritis Pain Drugs Regions by Revenue
  • 2.5.1 Global Top Osteoarthritis Pain Drugs Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Osteoarthritis Pain Drugs Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Osteoarthritis Pain Drugs Sales by Manufacturers
  • 3.1.1 Global Top Osteoarthritis Pain Drugs Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Osteoarthritis Pain Drugs Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Osteoarthritis Pain Drugs Sales in 2020
• 3.2 Global Osteoarthritis Pain Drugs Revenue by Manufacturers
  • 3.2.1 Global Top Osteoarthritis Pain Drugs Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Osteoarthritis Pain Drugs Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Osteoarthritis Pain Drugs Revenue in 2020
• 3.3 Global Osteoarthritis Pain Drugs Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Osteoarthritis Pain Drugs Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Osteoarthritis Pain Drugs Sales by Type
  • 4.1.1 Global Osteoarthritis Pain Drugs Historical Sales by Type (2016-2021)
  • 4.1.2 Global Osteoarthritis Pain Drugs Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2027)
• 4.2 Global Osteoarthritis Pain Drugs Revenue by Type
  • 4.2.1 Global Osteoarthritis Pain Drugs Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Osteoarthritis Pain Drugs Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2016-2027)
• 4.3 Global Osteoarthritis Pain Drugs Price by Type
  • 4.3.1 Global Osteoarthritis Pain Drugs Price by Type (2016-2021)
  • 4.3.2 Global Osteoarthritis Pain Drugs Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Osteoarthritis Pain Drugs Sales by Application
  • 5.1.1 Global Osteoarthritis Pain Drugs Historical Sales by Application (2016-2021)
  • 5.1.2 Global Osteoarthritis Pain Drugs Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2027)
• 5.2 Global Osteoarthritis Pain Drugs Revenue by Application
  • 5.2.1 Global Osteoarthritis Pain Drugs Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Osteoarthritis Pain Drugs Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2016-2027)
• 5.3 Global Osteoarthritis Pain Drugs Price by Application
  • 5.3.1 Global Osteoarthritis Pain Drugs Price by Application (2016-2021)
  • 5.3.2 Global Osteoarthritis Pain Drugs Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Osteoarthritis Pain Drugs Market Size by Type
  • 6.1.1 North America Osteoarthritis Pain Drugs Sales by Type (2016-2027)
  • 6.1.2 North America Osteoarthritis Pain Drugs Revenue by Type (2016-2027)
• 6.2 North America Osteoarthritis Pain Drugs Market Size by Application
  • 6.2.1 North America Osteoarthritis Pain Drugs Sales by Application (2016-2027)
  • 6.2.2 North America Osteoarthritis Pain Drugs Revenue by Application (2016-2027)
• 6.3 North America Osteoarthritis Pain Drugs Market Size by Country
  • 6.3.1 North America Osteoarthritis Pain Drugs Sales by Country (2016-2027)
  • 6.3.2 North America Osteoarthritis Pain Drugs Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Osteoarthritis Pain Drugs Market Size by Type
  • 7.1.1 Europe Osteoarthritis Pain Drugs Sales by Type (2017-2027)
  • 7.1.2 Europe Osteoarthritis Pain Drugs Revenue by Type (2017-2027)
• 7.2 Europe Osteoarthritis Pain Drugs Market Size by Application
  • 7.2.1 Europe Osteoarthritis Pain Drugs Sales by Application (2017-2027)
  • 7.2.2 Europe Osteoarthritis Pain Drugs Revenue by Application (2017-2027)
• 7.3 Europe Osteoarthritis Pain Drugs Market Size by Country
  • 7.3.1 Europe Osteoarthritis Pain Drugs Sales by Country (2017-2027)
  • 7.3.2 Europe Osteoarthritis Pain Drugs Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Osteoarthritis Pain Drugs Market Size by Type
  • 8.1.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Type (2018-2027)
• 8.2 Asia Pacific Osteoarthritis Pain Drugs Market Size by Application
  • 8.2.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Application (2018-2027)
• 8.3 Asia Pacific Osteoarthritis Pain Drugs Market Size by Region
  • 8.3.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Osteoarthritis Pain Drugs Market Size by Type
  • 9.1.1 Latin America Osteoarthritis Pain Drugs Sales by Type (2019-2027)
  • 9.1.2 Latin America Osteoarthritis Pain Drugs Revenue by Type (2019-2027)
• 9.2 Latin America Osteoarthritis Pain Drugs Market Size by Application
  • 9.2.1 Latin America Osteoarthritis Pain Drugs Sales by Application (2019-2027)
  • 9.2.2 Latin America Osteoarthritis Pain Drugs Revenue by Application (2019-2027)
• 9.3 Latin America Osteoarthritis Pain Drugs Market Size by Country
  • 9.3.1 Latin America Osteoarthritis Pain Drugs Sales by Country (2019-2027)
  • 9.3.2 Latin America Osteoarthritis Pain Drugs Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Osteoarthritis Pain Drugs Market Size by Type
  • 6.1.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Osteoarthritis Pain Drugs Market Size by Application
  • 6.2.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Osteoarthritis Pain Drugs Market Size by Country
  • 6.3.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Sino Biopharmaceutical
  • 11.1.1 Sino Biopharmaceutical Corporation Information
  • 11.1.2 Sino Biopharmaceutical Overview
  • 11.1.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Description
  • 11.1.5 Sino Biopharmaceutical Related Developments
• 11.2 Chugai Pharmaceutical
  • 11.2.1 Chugai Pharmaceutical Corporation Information
  • 11.2.2 Chugai Pharmaceutical Overview
  • 11.2.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Description
  • 11.2.5 Chugai Pharmaceutical Related Developments
• 11.3 Pfizer
  • 11.3.1 Pfizer Corporation Information
  • 11.3.2 Pfizer Overview
  • 11.3.3 Pfizer Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Pfizer Osteoarthritis Pain Drugs Product Description
  • 11.3.5 Pfizer Related Developments
• 11.4 Mikasa Seiyaku
  • 11.4.1 Mikasa Seiyaku Corporation Information
  • 11.4.2 Mikasa Seiyaku Overview
  • 11.4.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Mikasa Seiyaku Osteoarthritis Pain Drugs Product Description
  • 11.4.5 Mikasa Seiyaku Related Developments
• 11.5 Bayer
  • 11.5.1 Bayer Corporation Information
  • 11.5.2 Bayer Overview
  • 11.5.3 Bayer Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Bayer Osteoarthritis Pain Drugs Product Description
  • 11.5.5 Bayer Related Developments
• 11.6 Haohai Biological
  • 11.6.1 Haohai Biological Corporation Information
  • 11.6.2 Haohai Biological Overview
  • 11.6.3 Haohai Biological Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Haohai Biological Osteoarthritis Pain Drugs Product Description
  • 11.6.5 Haohai Biological Related Developments
• 11.7 SK Chemicals
  • 11.7.1 SK Chemicals Corporation Information
  • 11.7.2 SK Chemicals Overview
  • 11.7.3 SK Chemicals Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 SK Chemicals Osteoarthritis Pain Drugs Product Description
  • 11.7.5 SK Chemicals Related Developments
• 11.8 Taisho Pharmaceutical
  • 11.8.1 Taisho Pharmaceutical Corporation Information
  • 11.8.2 Taisho Pharmaceutical Overview
  • 11.8.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Description
  • 11.8.5 Taisho Pharmaceutical Related Developments
• 11.9 Zhejiang Chengyi Pharmaceutical
  • 11.9.1 Zhejiang Chengyi Pharmaceutical Corporation Information
  • 11.9.2 Zhejiang Chengyi Pharmaceutical Overview
  • 11.9.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Description
  • 11.9.5 Zhejiang Chengyi Pharmaceutical Related Developments
• 11.10 Freda
  • 11.10.1 Freda Corporation Information
  • 11.10.2 Freda Overview
  • 11.10.3 Freda Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Freda Osteoarthritis Pain Drugs Product Description
  • 11.10.5 Freda Related Developments
• 11.1 Sino Biopharmaceutical
  • 11.1.1 Sino Biopharmaceutical Corporation Information
  • 11.1.2 Sino Biopharmaceutical Overview
  • 11.1.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Description
  • 11.1.5 Sino Biopharmaceutical Related Developments
• 11.12 Jingfeng Pharmaceutical
  • 11.12.1 Jingfeng Pharmaceutical Corporation Information
  • 11.12.2 Jingfeng Pharmaceutical Overview
  • 11.12.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 Jingfeng Pharmaceutical Product Description
  • 11.12.5 Jingfeng Pharmaceutical Related Developments
• 11.13 Seikagaku Corporation
  • 11.13.1 Seikagaku Corporation Corporation Information
  • 11.13.2 Seikagaku Corporation Overview
  • 11.13.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 Seikagaku Corporation Product Description
  • 11.13.5 Seikagaku Corporation Related Developments
• 11.14 GSK
  • 11.14.1 GSK Corporation Information
  • 11.14.2 GSK Overview
  • 11.14.3 GSK Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.14.4 GSK Product Description
  • 11.14.5 GSK Related Developments
• 11.15 Sanofi
  • 11.15.1 Sanofi Corporation Information
  • 11.15.2 Sanofi Overview
  • 11.15.3 Sanofi Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.15.4 Sanofi Product Description
  • 11.15.5 Sanofi Related Developments
• 11.16 Crystal Genomics
  • 11.16.1 Crystal Genomics Corporation Information
  • 11.16.2 Crystal Genomics Overview
  • 11.16.3 Crystal Genomics Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.16.4 Crystal Genomics Product Description
  • 11.16.5 Crystal Genomics Related Developments
• 11.17 Johnson & Johnson
  • 11.17.1 Johnson & Johnson Corporation Information
  • 11.17.2 Johnson & Johnson Overview
  • 11.17.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.17.4 Johnson & Johnson Product Description
  • 11.17.5 Johnson & Johnson Related Developments
• 11.18 GlaxoSmithKline
  • 11.18.1 GlaxoSmithKline Corporation Information
  • 11.18.2 GlaxoSmithKline Overview
  • 11.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.18.4 GlaxoSmithKline Product Description
  • 11.18.5 GlaxoSmithKline Related Developments
• 11.19 Mylan
  • 11.19.1 Mylan Corporation Information
  • 11.19.2 Mylan Overview
  • 11.19.3 Mylan Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.19.4 Mylan Product Description
  • 11.19.5 Mylan Related Developments
• 11.20 Lilly
  • 11.20.1 Lilly Corporation Information
  • 11.20.2 Lilly Overview
  • 11.20.3 Lilly Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.20.4 Lilly Product Description
  • 11.20.5 Lilly Related Developments
• 11.21 Abbott Laboratories
  • 11.21.1 Abbott Laboratories Corporation Information
  • 11.21.2 Abbott Laboratories Overview
  • 11.21.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.21.4 Abbott Laboratories Product Description
  • 11.21.5 Abbott Laboratories Related Developments
• 11.22 Almatica Pharma
  • 11.22.1 Almatica Pharma Corporation Information
  • 11.22.2 Almatica Pharma Overview
  • 11.22.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.22.4 Almatica Pharma Product Description
  • 11.22.5 Almatica Pharma Related Developments
• 11.23 TEVA
  • 11.23.1 TEVA Corporation Information
  • 11.23.2 TEVA Overview
  • 11.23.3 TEVA Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.23.4 TEVA Product Description
  • 11.23.5 TEVA Related Developments
• 11.24 Iroko Pharmaceuticals
  • 11.24.1 Iroko Pharmaceuticals Corporation Information
  • 11.24.2 Iroko Pharmaceuticals Overview
  • 11.24.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.24.4 Iroko Pharmaceuticals Product Description
  • 11.24.5 Iroko Pharmaceuticals Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Osteoarthritis Pain Drugs Value Chain Analysis
• 12.2 Osteoarthritis Pain Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Osteoarthritis Pain Drugs Production Mode & Process
• 12.4 Osteoarthritis Pain Drugs Sales and Marketing
  • 12.4.1 Osteoarthritis Pain Drugs Sales Channels
  • 12.4.2 Osteoarthritis Pain Drugs Distributors
• 12.5 Osteoarthritis Pain Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Osteoarthritis Pain Drugs Industry Trends
• 13.2 Osteoarthritis Pain Drugs Market Drivers
• 13.3 Osteoarthritis Pain Drugs Market Challenges
• 13.4 Osteoarthritis Pain Drugs Market Restraints

14 Key Findings in The Global Osteoarthritis Pain Drugs Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details